Day: October 23, 2020

SMITHFIELD, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) — KS Bancorp, Inc. (the “Company”) (OTCBB: KSBI), parent company of KS Bank, Inc. (the “Bank”), announced unaudited results for the third quarter of 2020.The Company reported net income of $1,145,000 or $1.03 per diluted share, an increase of 17.3% for the three months ended September 30, 2020, compared to net income of $976,000 or $0.88 per diluted share, for the three months ended September 30, 2019. For the nine months ended September 30, 2020, the Company reported net income of $3.0 million, or $2.74 per diluted share compared to $2.7 million, or $2.44 per diluted share for the nine months ended September 30, 2019.Net interest income for the three months ended September 30, 2020, was $3.8 million as compared to $3.3 million for the comparable period in 2019. Noninterest income...

Funding will support families and communities across CanadaLOUISVILLE, Ky., Oct. 23, 2020 (GLOBE NEWSWIRE) — Papa John’s Canada announced the company raised more than $40 thousand through sales of the Shaq-a-Roni pizza for Boys & Girls Clubs of Canada to help address challenges posed by COVID-19 for kids and families, and to drive leadership development programs for kids in local communities.“Thanks to the generosity of each customer who ordered a Shaq-a-Roni pizza and the support of our franchisees and team members, we raised more than $40 thousand to support a cause very close to my heart,” said Shaquille O’Neal, Papa John’s Board Member and franchise owner.One dollar from every Shaq-a-Roni sold between June 29 and August 23 was donated to Boys & Girls Clubs of Canada.“The money raised through the Shaq-a-Roni is going...

Résultat des votes de l’Assemblée Générale Ordinaire du 22 octobre 2020Paris, le 23 octobre 2020 – L’Assemblée générale ordinaire de Galimmo, société en commandite par actions au capital de 23.325.312,80 euros dont le siège social est situé 37, rue de la Victoire à Paris (75009) et immatriculée au Registre du commerce et des sociétés de Paris sous le numéro 784 364 150, s’est tenue à huis clos à Paris le jeudi 22 octobre 2020, à 12 heures.8 actionnaires, représentant 29.143.140 actions, donnant droit à 29.143.140 voix ont voté par correspondance ou donné pouvoirs au Président, représentant 99,95 % du capital et des droits de vote de la Société.Le quorum étant réuni, l’assemblée a pu valablement délibérer sur l’ordre du jour.Pièce jointeGalimmo_Résultat des votes_AGO 22.10.2020

Acquisition Delivers on Commitment to the Promise of Digital Surgery to Improve Patient OutcomesDEERFIELD, Ill., Oct. 23, 2020 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announces the completion of the acquisition of Holo Surgical Inc., (‘Holosurgical’), a Chicago-based private technology company developing the revolutionary Augmented Reality and Artificial Intelligence platform (‘ARAI™’).“The completion of the Holosurgical acquisition brings an innovative surgical platform and world-class team into our organization, enabling us to advance the standard of care by reimagining what is possible through integrated intelligent technology,” said Terry Rich, President...

PRESS RELEASEOctober 23, 2020The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.Today, on October 23, 2020, an extraordinary general meeting was held in Saniona AB. A summary of the resolutions adopted follows below. All resolutions were adopted with the required majority of votes.Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrantsThe meeting resolved, in accordance with the proposal from the board of directors, to adopt an option program for all company employees, including the company’s CEO, the executive team (excluding the CSO Jørgen Drejer), vice presidents and all other employees. The employee options will cover all current employees, including the employees...

PRESSMEDDELANDE23 oktober 2020                                                        Idag, den 23 oktober 2020, hölls extra bolagsstämma i Saniona AB. Nedan följer en sammanfattning av de beslut som fattades. Samtliga beslut fattades med erforderlig majoritet.Beslut om (A) personaloptionsprogram; och (B) riktad emission av teckningsoptioner samt godkännande av överlåtelse av teckningsoptionerStämman beslutade, i enlighet med styrelsens förslag, om införande av ett optionsprogram för samtliga av bolagets anställda, inklusive bolagets verkställande direktör, ledningsgrupp (exklusive CSO Jørgen Drejer), Vice Presidents och samtliga övriga anställda. Personaloptionerna omfattar samtliga av bolagets nuvarande anställda (inklusive nyligen anställda och personer som kommer att anställas under perioden fram till nästa årsstämma). Stämman beslutade...

SOMERSET, N.J.et NEW YORK, 23 oct. 2020 (GLOBE NEWSWIRE) — Catalent (NYSE : CTLT), le plus grand fournisseur mondial de solutions de fabrication, de développement et de technologies d’administration de médicaments, de produits biologiques, de thérapies cellulaires et génétiques et de produits de santé grand public, et BrainStorm Cell Therapeutics Inc. (NASDAQ : BCLI), un développeur de premier plan de thérapies cellulaires pour les maladies neurodégénératives, ont annoncé aujourd’hui la conclusion d’un accord pour la fabrication de NurOwn®, la thérapie cellulaire autologue de BrainStorm en cours d’étude pour le traitement de la sclérose latérale amyotrophique (SLA), également connue sous le nom de maladie de Lou Gehrig, maladie du motoneurone ou maladie de Charcot.NurOwn entraîne la sécrétion par les cellules...

SOMERSET, N.J. und NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) — Catalent (NYSE: CTLT), der weltweit führende Anbieter von modernen Verabreichungstechnologien, Entwicklungs- und Fertigungslösungen für Arzneimittel, Biologika, Zell- und Gentherapien sowie Produkte im Bereich Verbrauchergesundheit, und BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), ein führender Entwickler von zellulären Therapien für die Behandlung neurodegenerativer Erkrankungen, gaben heute den Abschluss einer Vereinbarung zur Produktion von NurOwn® bekannt. Die autologe zelluläre Therapie von BrainStorm wird zur Behandlung der amyotrophen Lateralsklerose (ALS), auch als Lou-Gehrig-Syndrom oder Motoneuronerkrankung bezeichnet, erforscht.NurOwn induziert mesenchymale Stammzellen (MSC), um hohe Mengen an neurotrophen Faktoren (NTF) freizusetzen, die bekanntermaßen...